CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma.

Hu, Zhang-Wei; Sun, Wei; Wen, Yi-Hui; Ma, Ren-Qiang; Chen, Lin; Chen, Wen-Qing; Lei, Wen-Bin; Wen, Wei-Ping

Hu, Zhang-Wei; Sun, Wei; Wen, Yi-Hui; Ma, Ren-Qiang; Chen, Lin; Chen, Wen-Qing; Lei, Wen-Bin; Wen, Wei-Ping.

Afiliação

Hu ZW; Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Sun W; Otorhinolaryngology Institute, Sun Yat-sen University, Guangzhou, China.
Wen YH; Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Ma RQ; Otorhinolaryngology Institute, Sun Yat-sen University, Guangzhou, China.
Chen L; Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Chen WQ; Otorhinolaryngology Institute, Sun Yat-sen University, Guangzhou, China.
Lei WB; Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Wen WP; Otorhinolaryngology Institute, Sun Yat-sen University, Guangzhou, China.

Front Immunol ; 13: 952059, 2022.

Article em En | MEDLINE | ID: mdl-36045683

Assuntos

Neoplasias Pulmonares; Melanoma; Antígeno B7-H1/genética; Humanos; Inibidores de Checkpoint Imunológico; Imunoterapia; Neoplasias Pulmonares/patologia; Melanoma/tratamento farmacológico; Receptor de Morte Celular Programada 1

Palavras-chave

CD69; PD-1; SBK1; immunotherapy; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google